FindTrial
Sign In

Retrospective cohort study on the safety and efficacy of small molecule antiviral drugs in elderly patients with COVID-19

Retrospective cohort study on the safety and efficacy of small molecule antiviral drugs in elderly patients with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072750
Enrollment
Unknown
Registered
2023-06-25
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Exposure group (Small-molecule antiviral treatment group):No
Control group (Not treated with small-molecule antiviral drugs group):No

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: ? The actual age is 60 years and above; ? The nucleic acid test or antigen test of COVID-19 is positive.

Exclusion criteria

Exclusion criteria: ? no COVID-19 nucleic acid test and antigen test or unknown COVID-19 infection status; ? Laboratory examination data is missing.

Design outcomes

Primary

MeasureTime frame
Medicine-Nucleic acid negative conversion duration;—

Secondary

MeasureTime frame
CK?CK-MB?BNP?NT-ProBNP?TnT?hsTNI;ALT?AST?BUN?SCR;Medication-Symptom improvement duration;Medication - Discharge duration;—

Countries

China

Contacts

Public ContactPengfei Jin

Beijing Hospital

j790101@163.com+86 10 8513 3620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026